Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study

por Zhang, Jia-Tao, Liu, Si-Yang, Yan, Hong-Hong, Wu, Yi-Long, Nie, Qiang, Zhong, Wen-Zhao
Publicado 2019

Multiple primary malignancies involving lung cancer

por Li, Feng, Zhong, Wen-Zhao, Niu, Fei-Yu, Zhao, Ning, Yang, Jin-Ji, Yan, Hong-Hong, Wu, Yi-Long
Publicado 2015

A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous ce...

por Yang, Jin-Ji, Huang, Cheng, Chen, Gong-Yan, Song, Yong, Cheng, Ying, Yan, Hong-Hong, Zhou, Qing, Wu, Yi-Long
Publicado 2014

EGFR mutations in early‐stage and advanced‐stage lung adenocarcinoma: Analysis based on large‐scale data from China

por Pi, Can, Xu, Chong‐Rui, Zhang, Ming‐feng, Peng, Xiao‐xiao, Wei, Xue‐wu, Gao, Xing, Yan, Hong‐Hong, Zhou, Qing
Publicado 2018

Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma

por Liao, Lie-Qiang, Yan, Hong-Hong, Mai, Jun-Hao, Liu, Wei-Wei, Li, Hao, Guo, Zhu-Ming, Zeng, Zong-Yuan, Liu, Xue-Kui
Publicado 2016

RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

por Dong, Song, Guo, Ai-Lin, Chen, Zhi-Hong, Wang, Zhen, Zhang, Xu-Chao, Huang, Ying, Xie, Zhi, Yan, Hong-Hong, Cheng, Hua, Wu, Yi-Long
Publicado 2010

Impact of menopausal status and HER-2/neu protein on efficacy of EGFR-TKI in EGFR mutant patients with non-small cell lung cancer

por Yin, Zi-Jun, Tu, Hai-Yan, Fu, Ming, Zhong, Wen-Zhao, An, She-Juan, Yan, Hong-Hong, Chen, Hua-Jun, Lin, Hui-Ran, Wu, Yi-Long
Publicado 2018

Clinical features and intervention timing in patients with pregnancy-associated non-small-cell lung cancer

por Yang, Lei, He, Yun-Ting, Kang, Jin, Zheng, Ming-Ying, Chen, Zhi-Hong, Yan, Hong-Hong, Zhang, Xu-Chao, Yang, Jin-Ji, Wu, Yi-Long, Zhou, Qing
Publicado 2021

Plasma dynamic monitoring of soluble c-Met level for EGFR-TKI treatment in advanced non-small cell lung cancer

por Gao, Hong-Fei, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Guo, Wei-Bang, Zhou, Qing, Gou, Lou-Ying, Dong, Zhong-Yi, Wu, Yi-Long
Publicado 2016

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients

por Tian, Hong‐xia, Chen, Zhi‐hong, Jie, Guang‐Ling, Wang, Zhen, Yan, Hong‐hong, Wu, Si‐pei, Zhang, Shui‐lian, Lu, Dan‐xia, Zhang, Xu‐chao, Wu, Yi‐long
Publicado 2022

Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay

por Su, Jian, Zhang, Xu-Chao, An, She-Juan, Zhong, Wen-Zhao, Huang, Ying, Chen, Shi-Liang, Yan, Hong-Hong, Chen, Zhi-Hong, Guo, Wei-Bang, Huang, Xiao-Sui, Wu, Yi-Long
Publicado 2014

Three‐dimensional printed navigational template for localizing small pulmonary nodules: A case‐controlled study

por Fu, Rui, Chai, Yun‐Fei, Zhang, Jia‐Tao, Zhang, Tao, Chen, Xiao‐Kun, Dong, Song, Yan, Hong‐Hong, Yang, Xue‐Ning, Huang, Mei‐Ping, Wu, Yi‐Long, Zhuang, Jian, Zhong, Wen‐Zhao
Publicado 2020

Prophylactic air‐extraction strategy after thoracoscopic wedge resection

por Zhang, Jia‐Tao, Tang, Yi‐Chun, Lin, Jun‐Tao, Dong, Song, Nie, Qiang, Jiang, Ben‐Yuan, Yan, Hong‐Hong, Wen, Zheng‐Wei, Wu, Yue, Yang, Xue‐Ning, Wu, Yi‐Long, Zhong, Wen‐Zhao
Publicado 2018

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

por Zhou, Qing, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Xu, Chong-Rui, Su, Jian, Chen, Hua-Jun, Tu, Hai-Yan, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Publicado 2016

Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status

por An, She-Juan, Chen, Zhi-Hong, Su, Jian, Zhang, Xu-Chao, Zhong, Wen-Zhao, Yang, Jin-Ji, Zhou, Qing, Yang, Xue-Ning, Huang, Ling, Guan, Ji-Lin, Nie, Qiang, Yan, Hong-Hong, Mok, Tony S., Wu, Yi-Long
Publicado 2012

Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism

por Liu, Si‐Yang, Zhou, Jia‐Ying, Li, Wen‐Feng, Sun, Hao, Zhang, Yi‐Chen, Yan, Hong‐Hong, Chen, Zhi‐Hong, Chen, Chun‐Xiang, Ye, Jun‐Yi, Yang, Jin‐Ji, Zhou, Qing, Zhang, Xu‐Chao, Wu, Yi‐Long
Publicado 2020

Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer

por Deng, Jia-Yi, Gou, Qing, Yang, Lingling, Chen, Zhi-Hong, Yang, Ming-Yi, Yang, Xiao-Rong, Yan, Hong-Hong, Wei, Xue-Wu, Liu, Jia-Qi, Su, Jian, Zhong, Wen-Zhao, Xu, Chong-Rui, Wu, Yi-Long, Zhou, Qing
Publicado 2023

Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

por Bai, Xue, Wu, De-Hua, Ma, Si-Cong, Wang, Jian, Tang, Xin-Ran, Kang, Shuai, Fu, Qiang John, Cao, Chuan-Hui, Luo, He-San, Chen, Yu-Han, Zhu, Hong-Bo, Yan, Hong-Hong, Wu, Yi-Long, Dong, Zhong-Yi
Publicado 2020

Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study

por Dong, Song, Zhao, Ning, Deng, Wei, Sun, Hui-wen, Niu, Fei-yu, Yang, Jin-ji, Zhong, Wen-zhao, Li, Feng, Yan, Hong-hong, Xu, Chong-rui, Zhang, Qiu-yi, Yang, Xue-ning, Liao, Ri-qiang, Nie, Qiang, Wu, Yi-long
Publicado 2017

The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer

por Gou, Lan-Ying, Li, An-Na, Yang, Jin-Ji, Zhang, Xu-Chao, Su, Jian, Yan, Hong-Hong, Xie, Zhi, Lou, Na-Na, Liu, Si-Yang, Dong, Zhong-Yi, Gao, Hong-Fei, Zhou, Qing, Zhong, Wen-Zhao, Xu, Chong-Rui, Wu, Yi-Long
Publicado 2016